Human Identification Market is Expected to Reach $1.3 billion | MarketsandMarkets™
03 mai 2024 08h30 HE
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, May 03, 2024 (GLOBE NEWSWIRE) -- Human Identification market in terms of revenue was estimated to be worth $0.8 billion in 2024 and is poised to reach $1.3 billion by 2029, growing at a...
Ocuphire Pharma to Present at the Aegis Virtual Conference
03 mai 2024 08h00 HE
|
Ocuphire Pharma
FARMINGTON HILLS, Mich., May 03, 2024 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of...
Immuron Director Resignation
03 mai 2024 06h00 HE
|
Immuron Limited
MELBOURNE, Australia, May 03, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company, advises that Stephen...
Invivyd to Host Conference Call Discussing First Quarter 2024 Financial Results and Business Highlights
02 mai 2024 17h13 HE
|
Invivyd
WALTHAM, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced...
Tenaya Therapeutics to Highlight Growing Capabilities in Capsid Engineering, Gene Editing and Manufacturing at the American Society of Gene and Cell Therapy 27th Annual Meeting
02 mai 2024 17h00 HE
|
Tenaya Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver...
ClearPoint Neuro to Present Novel Research and Exhibit at the 27th American Society of Gene & Cell Therapy Annual Meeting in Baltimore
02 mai 2024 16h05 HE
|
ClearPoint Neuro, Inc.
Novel drug delivery research to be presented by ClearPoint Neuro Biologics team at ASGCT 2024 Annual Meeting in Baltimore
OrthoPediatrics Corp. Receives “Breakthrough Device” Designation from FDA for eLLi™ Growing Rod System for Pediatric Patients with Scoliosis
02 mai 2024 16h05 HE
|
OrthoPediatrics Corp.
WARSAW, Ind., May 02, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today...
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Corporate Update
02 mai 2024 16h01 HE
|
Xenon Pharmaceuticals Inc.
VANCOUVER, British Columbia, May 02, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, today announced it will report its first...
Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., to its Board of Directors
02 mai 2024 16h01 HE
|
Vor Biopharma
CAMBRIDGE, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced the appointment of Fouad Namouni, M.D., to its Board...
Novotech 发布囊性纤维化临床试验现状分析报告，为生物技术研究规划提供依据
02 mai 2024 15h35 HE
|
Novotech
波士顿, May 03, 2024 (GLOBE NEWSWIRE) -- Novotech，一家与各大生物技术公司合作，在各个阶段加速开发先进的新型疗法的，提供全方位服务的全球性临床合同研究组织 (CRO) 发布了一份题为囊性纤维化——全球临床实验现状的综合研究报告。 报告以数据为基础，回顾了囊性纤维化 (CF)...